Trump drug pricing policy having impacts here as well

episode

Health Report - Separate stories podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 12PM EDT 5 min · 22 Sep 2026 · NPR News Now

12PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Des Décisions Difficiles À Venir Pour Le Canadien | Le Sick Podcast Avec Tony Marinaro 22/09/26 1h 31m · 22 Sep 2026 · The Sick Podcast with Tony Marinaro / Le Sick Podcast avec Tony Marinaro

JTP: Bateman Hurt, 2027 Lookahead & Bisons’ Josh Winckowski 1h 39m · 22 Sep 2026 · Blue Jays Talk

ep 399 | What does a Fed hiking cycle mean for markets? 8 min · 22 Sep 2026 · On Point

Ep. 2065 - How They Legally Killed An 83-Year-Old Grandmother 46 min · 22 Sep 2026 · The Michael Knowles Show

Report any issue

Source

Recorded18 Sep 2026

Publisherabc.net.au ↗

Handlerec:20440659

Show notes

PBS listings for medications for three separate conditions have run up against President Trump’s most favoured nation pricing policy this year. People with breast cancer, multiple sclerosis and opioid addiction have so far been affected. New research on this policy and it’s impact shows there will likely be more of these disruptions to come.Guest/sDr Thomas Hwang, Assistant Professor at Brigham and Women's Hospital and faculty at Harvard Medical School ReferencesMost-favoured-nation pricing for prescription drugs in US Medicare: a cohort study

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in